US Stock Exchanges Face Earnings Test as Trading Boom Meets Crypto Competition 
Macquarie Names Greg Ward as CEO, Signaling Stability and Strategic Continuity 
Gold Price Surges Above $4,100 as Middle East Tensions Boost Safe-Haven Demand 
Asian Stocks Rally on AI Spending Optimism as Middle East Tensions Push Oil to Six-Week High 
Domino’s Weighs Appeal After Australian Court Rules Workers Were Misled on Pay 
Japan PM Sanae Takaichi Unveils Growth Plan as BOJ Independence Concerns Lift Bond Yields 
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors 
ASEAN Ministers Warn Middle East Conflict Threatens Regional Stability and Energy Security 
Chalco Shares Jump as Chinalco Plans Up to $300 Million Stake Increase 
Samsung Eyes Up to $1.14 Billion Investment in AI Startup Mistral 
US Dollar Climbs to Weekly High as Middle East Tensions Lift Treasury Yields and Safe-Haven Demand 
GM Q2 Earnings Beat Estimates as General Motors Raises 2026 Profit Outlook 
Nike Shifts China Online Sales Strategy to Boost Brand and Fight Local Rivals 
Saudi Oil Tankers Reverse Course as Houthi Threats Disrupt Red Sea Shipping 
Gold Price Jumps Near 2% Above $4,080 as Middle East Tensions Lift Safe-Haven Demand 
South Korea Q2 GDP Beats Forecasts as AI Chip Exports Drive Growth 
Lotte Biologics is reportedly accused of stealing the trade secrets of its rival, Samsung Biologics. A probe into the case was already launched by prosecutors, and officials will be especially checking into some of the company’s employees who were suspected of the crime.
According to The Korea Times, the Incheon District Prosecutors' Office dispatched investigators last week to search the headquarters of Lotte Biologics located in Seoul’s Lotte World Tower. The raid took place on Friday, Oct. 7, and during the search, authorities said they were able to secure the computers of three former workers who were revealed to have moved from Samsung Biologics to Lotte Biologics, but their job positions in the company were not revealed.
Prior to the investigation, it was reported that Samsung Biologics filed to apply for a court directive for the infringement of its company trade secrets in May. In the application for the injunction, it mentioned its three former employees who moved to Lotte Biologics in July.
While their job roles were not disclosed, the three people were said to have work duties related to Samsung Biologics’ core business. The trio was also said to have printed a large number of company documents before transferring to its rival firm, Lotte Biologics.
The Incheon District Court responded to the application by granting Lotte’s request and issuing an injunction against the infringement of trade secrets that were filed by Samsung’s biotechnology business unit on July 29. The directive was to prevent the leak of any business secrets that could be utilized by Lotte Biologics for its benefit.
"We cannot reveal the specifics of the investigation including the search and seizure," the prosecution body commented with regard to the recent raid at the Lotte Biologics HQ
Meanwhile, the biological CDMO (Contract Development Manufacturing Organization) division of the Lotte Group was said to have started hiring bio professionals in the last quarter of 2021 as it was preparing to jump into the bio business. Based on the reports, many of the new hires were recruited from Samsung Biologics.
